Regeneron Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2024: USD 789.50 M

Regeneron Pharmaceuticals, Inc. Accounts Payable is USD 789.50 M for the year ending December 31, 2024, a 30.15% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Regeneron Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2023 was USD 606.60 M, a 2.95% change year over year.
  • Regeneron Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2022 was USD 589.20 M, a 4.47% change year over year.
  • Regeneron Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2021 was USD 564.00 M, a 18.61% change year over year.
  • Regeneron Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2020 was USD 475.50 M, a 13.73% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities